Clinical Pharmacology & Biopharmaceutics
Open Access

Effect of Evidence-Based Nursing Practise on Protocol Adherence inClinical Trials of Anticancer Drugs

Fengzhen Chen^*

Department of Nursing, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Received Date: Mar 16, 2022 / Published Date: Nov 30, 2022

Citation: Chen F (2022) Effect of Evidence-Based Nursing Practise on Protocol Adherence in Clinical Trials of Anticancer Drugs. Clin Pharmacol Biopharm, 11: 296.

Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156

Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2022 Chen F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF | Peer-reviewed Full Article

This study aimed to construct evidence-based malignant neoplasm drug run nursing management norms to confirm the security and quality of run nursing. This before-after study was allotted to finish the proof implementation in an exceedingly cancer hospital in Shanghai, China. Seven review indicators were developed and reviewed in one {phase I run phase I clinical trial clinical test} clinical trial center and 2 medical specialty wards. The corresponding evidencebased intervention program was developed, and also the completion rate of excellent clinical observe certification, protocol coaching, delegation of duties, qualification rate of administration, sampling and document recording in malignant neoplasm drug clinical trials before and once implementation were compared. After implementation, the completion rate of protocol coaching, delegation of duties, and also the qualification rate of document recording were considerably more than those of the baseline review, whereas the completion rate of excellent clinical observe certification and also the qualification rate of sampling failed to considerably disagree from those discovered at the baseline review. There was no administration or infusion device-related protocol deviation throughout the baseline and post reviews.